INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 103 filers reported holding INHIBRX INC in Q3 2022. The put-call ratio across all filers is 34.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,491 | -35.7% | 3,678 | -9.1% | 0.04% | -33.9% |
| Q2 2023 | $104,982 | +61.8% | 4,044 | +17.6% | 0.06% | +72.2% |
| Q1 2023 | $64,875 | -44.7% | 3,438 | -27.8% | 0.04% | -41.0% |
| Q4 2022 | $117,311 | -46.7% | 4,761 | -61.2% | 0.06% | -30.7% |
| Q3 2022 | $220,000 | +59.4% | 12,263 | +0.7% | 0.09% | +72.5% |
| Q2 2022 | $138,000 | +56.8% | 12,172 | +206.8% | 0.05% | +30.8% |
| Q1 2022 | $88,000 | -51.9% | 3,968 | -5.5% | 0.04% | -43.5% |
| Q4 2021 | $183,000 | -36.9% | 4,200 | -51.7% | 0.07% | -46.1% |
| Q3 2021 | $290,000 | +15.1% | 8,695 | -5.0% | 0.13% | +23.1% |
| Q2 2021 | $252,000 | +72.6% | 9,153 | +25.9% | 0.10% | +67.7% |
| Q1 2021 | $146,000 | -37.9% | 7,268 | +1.9% | 0.06% | -36.7% |
| Q4 2020 | $235,000 | – | 7,133 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |